Summary of Patient Characteristics and Enhanced Expression of Cyclin E
| Phenotype . | No. of Samples . | Enhanced Expression of Cyclin E . | |
|---|---|---|---|
| . | . | No. . | % . |
| AML M1 | 18 | 8 (2)* | 44 |
| M2 | 32 | 3 | 9 |
| M3 | 13 | 0 | 0 |
| M4 | 8 | 3 (2) | 38 |
| M5 | 14 | 9 (6) | 64 |
| Total | 85 | 23 (10) | 27 |
| Phenotype . | No. of Samples . | Enhanced Expression of Cyclin E . | |
|---|---|---|---|
| . | . | No. . | % . |
| AML M1 | 18 | 8 (2)* | 44 |
| M2 | 32 | 3 | 9 |
| M3 | 13 | 0 | 0 |
| M4 | 8 | 3 (2) | 38 |
| M5 | 14 | 9 (6) | 64 |
| Total | 85 | 23 (10) | 27 |
Numbers in parentheses represent the number of samples with very high cyclin E expression.